Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China · Delayed Price · Currency is CNY 7.66
-0.08 (-1.03%)
Jul 25, 2025, 2:45 PM CST
Jinghua Pharmaceutical Group Company Description
Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China.
Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs.
The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China.
Jinghua Pharmaceutical Group Co., Ltd.
| Country | China |
| Founded | 1957 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,490 |
| CEO | Jian Cheng |
Contact Details
Address: No 20, 3 Haibin Road Nantong, Jiangsu Province 226407 China | |
| Phone | 86 513 8560 9405 |
| Website | jinghuapharm.com |
Stock Details
| Ticker Symbol | 002349 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000L14 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jian Cheng | GM, Chief Financial Officer and Director |
| Yuxiang Wu | Vice Chairman |
| Jianfeng Wang | Board Secretary |
| Qianyong Zhu | Deputy General Manager |